Becton, Dickinson and Company

Other

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

Clinical Trials↗

All sponsored trials (all statuses)

Activity

Key Events

Sep 2, 2026TrialAn Observational, Multinational, In Hospital Evaluation of Catheter Utilization Rates in Female Patients Using Indwelling Urinary Catheters and the PureWick™ Flex Female External Catheter Across Europe and the Middle East

Aug 27, 2026TrialHemoSphere Alta Clinical Development Study

Jul 14, 2026TrialAn Open-label Pilot Study Conducted in the UK to Evaluate the Clinical Benefits of the PureWick™ Female External Catheter System Compared to Indwelling Urinary Catheters in Female Patients Receiving Home-based Care

Jul 9, 2026TrialContinuous Blood Pressure Monitoring During Outpatient Surgery

Jul 9, 2026TrialClearSight NextGen System Clinical Development Study

Jul 9, 2026TrialAssessing for Personalized Blood Pressure Targets During Cardiopulmonary Bypass With the Proprietary Cerebral Adaptive Index: A Pilot Investigation

Jul 9, 2026TrialAcumen HPI Smart Alerts and Smart Trends to Improve Compliance With an Intra-operative Hemodynamic Management Algorithm and Reduce Renal Injury Following Major Elective Noncardiac Surgery.

Jun 21, 2017TrialEffectiveness of an Antimicrobial Agent for Preoperative Skin Preparation

1 more events

Jun 21, 2017TrialEvaluation of the Antimicrobial Effectiveness of an Antimicrobial Cloth

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Regulatory

Regulatory Timeline

19852 events

FDANov 29

Betadine — E-Z SCRUB 201

Application NDA019240 (NDA)

FDANov 29

Betadine — E-Z SCRUB 201

Application NDA019240 (NDA)

19862 events

FDADec 17

Betadine — BETADINE

Application NDA018634 (NDA)

FDADec 17

Betadine — BETADINE

Application NDA018634 (NDA)

19872 events

FDAJan 7

Betadine — E-Z SCRUB 241

Application NDA019476 (NDA)

FDAJan 7

Betadine — E-Z SCRUB 241

Application NDA019476 (NDA)

19894 events

FDAJul 25

Betadine — E-Z PREP

Application NDA019382 (NDA)

FDAJul 25

Betadine — E-Z PREP

Application NDA019382 (NDA)

FDAMar 31

Betadine — POVIDONE IODINE

Application NDA019522 (NDA)

FDAMar 31

Betadine — POVIDONE IODINE

Application NDA019522 (NDA)

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)